Drug name - Nubeqa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8975254 BAYER HEALTHCARE Androgen receptor modulating compounds
Oct, 2030

(8 years from now)

US9657003 BAYER HEALTHCARE Androgen receptor modulating compounds
Oct, 2030

(8 years from now)

US11046713 BAYER HEALTHCARE Androgen receptor modulating compounds
Oct, 2030

(8 years from now)

US10711013 BAYER HEALTHCARE Androgen receptor modulating compounds
Oct, 2030

(8 years from now)

US10383853 BAYER HEALTHCARE Carboxamide derivative and its diastereomers in stable crystalline form
Jan, 2036

(13 years from now)

US10010530 BAYER HEALTHCARE Carboxamide derivative and its diastereomers in stable crystalline form
Jan, 2036

(13 years from now)

US11168058 BAYER HEALTHCARE Manufacture of a crystalline pharmaceutical product
Feb, 2038

(15 years from now)

CN101410016B BAYER HEALTHCARE Fungicidal Compositions
Feb, 2027

(4 years from now)

CN101410016A BAYER HEALTHCARE Fungicidal Compositions
Feb, 2027

(4 years from now)

CN105061313B BAYER HEALTHCARE Androgen Receptor Modulator Compounds
Oct, 2030

(8 years from now)

CN102596910A BAYER HEALTHCARE Androgen Receptor Modulator Compounds
Oct, 2030

(8 years from now)

CN102596910B BAYER HEALTHCARE Androgen Receptor Modulator Compounds
Oct, 2030

(8 years from now)

CN105061313A BAYER HEALTHCARE Androgen Receptor Regulation Compound
Oct, 2030

(8 years from now)

IN304033B BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

IN201200848P2 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP1986495A2 BAYER HEALTHCARE Fungicidal Compositions
Feb, 2027

(4 years from now)

EP1986495B1 BAYER HEALTHCARE Fungicidal Compositions
Feb, 2027

(4 years from now)

EP3369732B1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP3369732A1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP3056485B1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP3056485A1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP2493858B1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP2493858A1 BAYER HEALTHCARE Androgen Receptor Modulating Compounds
Oct, 2030

(8 years from now)

EP3250554A1 BAYER HEALTHCARE A Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
Jan, 2036

(13 years from now)

EP3250554B1 BAYER HEALTHCARE A Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form
Jan, 2036

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835515 BAYER HEALTHCARE Carboxamide derivative and its diastereomers in stable crystalline form Jan, 2036

(13 years from now)

Drugs and Companies using DAROLUTAMIDE ingredient

Treatment: Treatment of patients with non-metastatic castration resistant prostate cancer

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
300MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.